Home » INDIAN PHARMA SEC UPSET WITH PATENTS ORDINANCE AS CRUCIAL SAFEGUARDS MISSED OUT IN THE BILL
INDIAN PHARMA SEC UPSET WITH PATENTS ORDINANCE AS CRUCIAL SAFEGUARDS MISSED OUT IN THE BILL
While the Union Government issued Patents Ordinance fulfilling obligations and commitments under the TRIPS Agreement, which has opened the product patent regime in pharmaceuticals, food and agro-chemicals, the country's pharmaceutical industry including large, medium and small sectors is disappointed to find that some crucial points have either been left out or have been treated in a half hearted manner in the Ordinance.
Pharmabiz.com (http://www.pharmabiz.com/article/detnews.asp?articleid=25498)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct